Cargando…

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children

BACKGROUND: Pretreatment HIV drug resistance (PDR) can impair virological response to ART, jeopardizing effective treatment for children. METHODS: Children aged ≤12 years initiated first-line ART in Uganda during 2010–11. Baseline and 6 monthly viral load (VL) and genotypic resistance testing if VL ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kityo, Cissy, Boerma, Ragna S., Sigaloff, Kim C. E., Kaudha, Elizabeth, Calis, Job C. J., Musiime, Victor, Balinda, Sheila, Nakanjako, Rita, Boender, T. Sonia, Mugyenyi, Peter N., Rinke de Wit, Tobias F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890670/ https://www.ncbi.nlm.nih.gov/pubmed/28673027 http://dx.doi.org/10.1093/jac/dkx188

Ejemplares similares

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda
por: Kityo, Cissy, et al.
Publicado: (2016)

Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study
por: Boender, T. Sonia, et al.
Publicado: (2012)

Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure
por: Boerma, Ragna S., et al.
Publicado: (2017)

High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children
por: Boerma, Ragna S, et al.
Publicado: (2016)

Sequencing paediatric antiretroviral therapy in the context of a public health approach
por: Boerma, Ragna S, et al.
Publicado: (2015)

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts
por: Bajunirwe, Francis, et al.
Publicado: (2018)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
por: Inzaule, Seth C., et al.
Publicado: (2018)

Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2023)

Clinical Evaluation of an Affordable Qualitative Viral Failure Assay for HIV Using Dried Blood Spots in Uganda
por: Balinda, Sheila N., et al.
Publicado: (2016)

Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique
por: Lamorde, Mohammed, et al.
Publicado: (2014)

Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study
por: Nichols, Brooke E, et al.
Publicado: (2014)

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans
por: Nanzigu, Sarah, et al.
Publicado: (2013)

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa
por: Kityo, Cissy, et al.
Publicado: (2017)

Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis
por: von Braun, Amrei, et al.
Publicado: (2017)

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV
por: Fitzgerald, Felicity C, et al.
Publicado: (2019)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2017)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2016)

Performance and Logistical Challenges of Alternative HIV-1 Virological Monitoring Options in a Clinical Setting of Harare, Zimbabwe
por: Ondoa, Pascale, et al.
Publicado: (2014)

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda
por: Bajunirwe, Francis, et al.
Publicado: (2016)

Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults
por: Lamorde, Mohammed, et al.
Publicado: (2012)

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study
por: Bajunirwe, Francis, et al.
Publicado: (2019)

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term
por: Boyce, Ceejay L., et al.
Publicado: (2022)

Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts
por: Bijker, Rimke, et al.
Publicado: (2017)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation
por: Ogbenna, Ann Abiola, et al.
Publicado: (2020)

Plasma Efavirenz Exposure, Sex, and Age Predict Virological Response in HIV-Infected African Children
por: Bienczak, Andrzej, et al.
Publicado: (2016)

Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries
por: Gibson, Richard M., et al.
Publicado: (2017)

Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2017)

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy — China, 2018–2019
por: Li, Miaomiao, et al.
Publicado: (2022)

2528. Inflammation and Plasma Selenium and Chromium in Ugandan Children Living with HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study
por: Kamulegeya, Adriane, et al.
Publicado: (2021)

Eating away from home is associated with overweight and obesity among Ugandan adults: the 2014 Uganda non-communicable disease risk factor survey
por: Kityo, Anthony, et al.
Publicado: (2022)

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
por: Paton, Nicholas I, et al.
Publicado: (2017)

Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic
por: Sebunya, Robert, et al.
Publicado: (2013)

Perceptions of Strategies and Intervention Approaches for HIV Self-Management among Ugandan Adolescents: A Qualitative Study
por: Mutumba, Massy, et al.
Publicado: (2019)

Infection with HIV-1 subtype D among acutely infected Ugandans is associated with higher median concentration of cytokines compared to subtype A
por: Kapaata, Anne, et al.
Publicado: (2022)

Fanconi–Bickel syndrome in a Ugandan child – diagnostic challenges in resource-limited settings: a case report
por: Piloya, Thereza, et al.
Publicado: (2020)

Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy
por: Flynn, Andrew G., et al.
Publicado: (2017)

Virologic suppression and associated factors in HIV infected Ugandan female sex workers: a cross-sectional study
por: Owachi, Darius, et al.
Publicado: (2021)

Pyrethroid Resistance Aggravation in Ugandan Malaria Vectors Is Reducing Bednet Efficacy
por: Tchouakui, Magellan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b5g396um435t68bsrigfeh5894